213 related articles for article (PubMed ID: 15601827)
21. The Retinoic acid receptor alpha (RARalpha) chimeric proteins PML-, PLZF-, NPM-, and NuMA-RARalpha have distinct intracellular localization patterns.
Hummel JL; Zhang T; Wells RA; Kamel-Reid S
Cell Growth Differ; 2002 Apr; 13(4):173-83. PubMed ID: 11971817
[TBL] [Abstract][Full Text] [Related]
22. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
[TBL] [Abstract][Full Text] [Related]
23. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
Duprez E; Lillehaug JR; Naoe T; Lanotte M
Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787
[TBL] [Abstract][Full Text] [Related]
24. Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice.
Zimonjic DB; Pollock JL; Westervelt P; Popescu NC; Ley TJ
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13306-11. PubMed ID: 11087871
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ
Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433
[TBL] [Abstract][Full Text] [Related]
26. The cleavage product deltaPML-RARalpha contributes to all-trans retinoic acid-mediated differentiation in acute promyelocytic leukemia cells.
Jing Y; Xia L; Lu M; Waxman S
Oncogene; 2003 Jun; 22(26):4083-91. PubMed ID: 12821942
[TBL] [Abstract][Full Text] [Related]
27. [Comparative study of two fusion retinoic acid receptor alpha in acute promyelocytic leukemia].
Zhong H; Dong S; Chen G; Jiang X; Xia Z; Yi N; Wang Z; Chen S; Xu Y; Chen L
Zhonghua Xue Ye Xue Za Zhi; 1997 Jul; 18(7):339-42. PubMed ID: 15624327
[TBL] [Abstract][Full Text] [Related]
28. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
Lo-Coco F; Hasan SK
Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
[TBL] [Abstract][Full Text] [Related]
29. PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cells.
Fu S; Consoli U; Hanania EG; Zu Z; Claxton DF; Andreeff M; Deisseroth AB
Clin Cancer Res; 1995 Jun; 1(6):583-90. PubMed ID: 9816019
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARalpha and PML-RARalpha.
Gianni' M; Boldetti A; Guarnaccia V; Rambaldi A; Parrella E; Raska I; Rochette-Egly C; Del Sal G; Rustighi A; Terao M; Garattini E
Cancer Res; 2009 Feb; 69(3):1016-26. PubMed ID: 19155306
[TBL] [Abstract][Full Text] [Related]
31. Targeting PML/RARalpha transcript with DNAzymes results in reduction of proliferation and induction of apoptosis in APL cells.
Kabuli M; Yin JA; Tobal K
Hematol J; 2004; 5(5):426-33. PubMed ID: 15448669
[TBL] [Abstract][Full Text] [Related]
32. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model.
Kelly LM; Kutok JL; Williams IR; Boulton CL; Amaral SM; Curley DP; Ley TJ; Gilliland DG
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8283-8. PubMed ID: 12060771
[TBL] [Abstract][Full Text] [Related]
33. A protease-resistant PML-RAR{alpha} has increased leukemogenic potential in a murine model of acute promyelocytic leukemia.
Uy GL; Lane AA; Welch JS; Grieselhuber NR; Payton JE; Ley TJ
Blood; 2010 Nov; 116(18):3604-10. PubMed ID: 20647568
[TBL] [Abstract][Full Text] [Related]
34. Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient.
Koken MH; Daniel MT; Gianni M; Zelent A; Licht J; Buzyn A; Minard P; Degos L; Varet B; de Thé H
Oncogene; 1999 Jan; 18(4):1113-8. PubMed ID: 10023688
[TBL] [Abstract][Full Text] [Related]
35. NLS-RARα contributes to differentiation block and increased leukemogenic potential in vivo.
Xiong L; Zhong L; Yu L; Dan W; Ye J; Li J; Liu D; Yuan Z; Yao J; Zhong P; Liu J; Liu B
Cell Signal; 2020 Jan; 65():109431. PubMed ID: 31654721
[TBL] [Abstract][Full Text] [Related]
36. [Detection of PML/RARalpha gene transcripts in 46 newly diagnosed acute promyelocytic leukemia patients by real-time quantitative reverse-transcription polymerase chain reaction].
Zhu HH; Liu YR; Qin YZ; Li JL; Chang Y; Wang YZ; Shan FX; Jiang B; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):1-5. PubMed ID: 17490509
[TBL] [Abstract][Full Text] [Related]
37. S100A3 a partner protein regulating the stability/activity of RARα and PML-RARα in cellular models of breast/lung cancer and acute myeloid leukemia.
Gianni M; Terao M; Kurosaki M; Paroni G; Brunelli L; Pastorelli R; Zanetti A; Lupi M; Acquavita A; Bolis M; Fratelli M; Rochette-Egly C; Garattini E
Oncogene; 2019 Apr; 38(14):2482-2500. PubMed ID: 30532072
[TBL] [Abstract][Full Text] [Related]
38. Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies.
Koken MH; Reid A; Quignon F; Chelbi-Alix MK; Davies JM; Kabarowski JH; Zhu J; Dong S; Chen S; Chen Z; Tan CC; Licht J; Waxman S; de Thé H; Zelent A
Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10255-60. PubMed ID: 9294197
[TBL] [Abstract][Full Text] [Related]
39. In vitro inhibition of promyelocytic leukemia/retinoic acid receptor-alpha (PML/RARalpha) expression and leukemogenic activity by DNA/LNA chimeric antisense oligos.
Caprodossi S; Galluzzi L; Biagetti S; Della Chiara G; Pelicci PG; Magnani M; Fanelli M
Oncol Res; 2005; 16(3):157-66. PubMed ID: 16925116
[TBL] [Abstract][Full Text] [Related]
40. Alteration in the cellular response to retinoic acid of a human acute promyelocytic leukemia cell line, UF-1, carrying a patient-derived mutant PML-RARalpha chimeric gene.
Sato A; Imaizumi M; Hoshi Y; Rikiishi T; Fujii K; Kizaki M; Kagechika H; Kakizuka A; Hayashi Y; Iinuma K
Leuk Res; 2004 Sep; 28(9):959-67. PubMed ID: 15234573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]